Physician profile
Andrew Davis
NPI 1700273539
$2,458.26
in general payments reported to CMS, 2019-2025
21 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $33.24 · 2021: $146 · 2022: $815 · 2023: $781 · 2024: $226 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $917.12 | 2021-2025 | Clareon, Hydrus Microstent, Total30 |
| Biotissue Holdings INC. | $269.32 | 2021-2022 | |
| Abbvie INC. | $216.53 | 2022-2025 | Xen Glaucoma Treatment System, Alphagan P, Lumigan |
| Sun Pharmaceutical Industries INC. | $161.41 | 2021-2025 | |
| New World Medical,INC. | $159.01 | 2023 | |
| Shire North American Group INC | $124.82 | 2019 | |
| Bausch & Lomb Americas INC. | $117.95 | 2022-2025 | Miebo, Xiidra |
| Rayner Intraocular Lenses Limited | $103.41 | 2024-2025 | Rayner Cataract Set 1, Rayone Aspheric, Rayone Emv |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.03 | 2021 | |
| Ocular Therapeutix, INC. | $46.25 | 2022-2024 | Dextenza |
| Thea Pharma INC. | $45.78 | 2023-2025 | Iyuzeh |
| Rxsight INC | $40.75 | 2022 | |
| Lensar, INC. | $36.80 | 2025 | Lensar Laser System |
| Glaukos Corporation | $33.24 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $32.48 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $25.14 | 2025 | Oxervate |
| Harrow Eye, LLC | $22.12 | 2025 | Iheezo |
| Mallinckrodt Hospital Products INC. | $17.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.05 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $14.63 | 2022 | |
| Oasis Medical, INC. | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.